mFOLFOX6-话题@MedSci

#mFOLFOX6#

10篇内容 | 1213人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2257281, encodeId=b781225e28114, content=<a href='/topic/show?id=0a9e922085f' target=_blank style='color:#2F92EE;'>#贝伐珠单抗#</a> <a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a> <a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a> <a href='/topic/show?id=bb7332335bd' target=_blank style='color:#2F92EE;'>#利鲁唑#</a>, objectTitle=Clin Cancer Res：利鲁唑联合mFOLFOX6和贝伐珠单抗治疗转移性结直肠癌：一项I期临床试验, objectType=article, longId=868341, objectId=9d8c86834161, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240806/1722908667203_8538692.png, objectUrl=/article/show_article.do?id=9d8c86834161, replyNumber=0, likeNumber=18, createdTime=2025-03-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=9d8c86834161, moduleTitle=Clin Cancer Res：利鲁唑联合mFOLFOX6和贝伐珠单抗治疗转移性结直肠癌：一项I期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d8c86834161)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1598539, encodeId=19fa1598539b8, content=<a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a>, objectTitle=J Clin Oncol：肝切除术后进行mFOLFOX6方案辅助化疗可显著延长仅肝转移的结直肠癌患者的无病生存期！, objectType=article, longId=217215, objectId=63bc21e215a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63bc21e215a3, replyNumber=0, likeNumber=85, createdTime=2021-09-18, rootId=0, userName=zhucaizhong7772, userId=dae718623804, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63bc21e215a3, moduleTitle=J Clin Oncol：肝切除术后进行mFOLFOX6方案辅助化疗可显著延长仅肝转移的结直肠癌患者的无病生存期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63bc21e215a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598538, encodeId=7457159853862, content=<a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a>, objectTitle=J Clin Oncol：Andecaliximab联合mFOLFOX6方案作为晚期胃/胃食管交界腺癌的一线疗法的3期试验结果, objectType=article, longId=207490, objectId=06e320e49013, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06e320e49013, replyNumber=0, likeNumber=0, createdTime=2021-02-24, rootId=0, userName=zhucaizhong7772, userId=dae718623804, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06e320e49013, moduleTitle=J Clin Oncol：Andecaliximab联合mFOLFOX6方案作为晚期胃/胃食管交界腺癌的一线疗法的3期试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06e320e49013)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598537, encodeId=f447159853ece, content=<a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a>, objectTitle=Lancet oncol：3期试验：FOLFOXIRI+贝伐珠单抗预治疗/再治疗转移性结直肠癌的效果优于mFOLFOX6+贝伐单抗/FOLFIRI+贝伐单抗, objectType=article, longId=190232, objectId=9131190232f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9131190232f7, replyNumber=0, likeNumber=67, createdTime=2020-03-19, rootId=0, userName=zhucaizhong7772, userId=dae718623804, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9131190232f7, moduleTitle=Lancet oncol：3期试验：FOLFOXIRI+贝伐珠单抗预治疗/再治疗转移性结直肠癌的效果优于mFOLFOX6+贝伐单抗/FOLFIRI+贝伐单抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9131190232f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598536, encodeId=c68b1598536e0, content=<a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a>, objectTitle=DCR：化放疗后巩固mFOLFOX6化疗可改善晚期直肠癌患者的生存率, objectType=article, longId=150473, objectId=28f61504e3f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28f61504e3f0, replyNumber=0, likeNumber=90, createdTime=2018-10-08, rootId=0, userName=zhucaizhong7772, userId=dae718623804, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28f61504e3f0, moduleTitle=DCR：化放疗后巩固mFOLFOX6化疗可改善晚期直肠癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28f61504e3f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598535, encodeId=5d241598535bd, content=<a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a>, objectTitle=CLIN CANCER RES：Andecaliximab单药或联合mFOLFOX6治疗晚期胃及胃食管交界处腺癌, objectType=article, longId=147490, objectId=2c3e14e490ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c3e14e490ab, replyNumber=0, likeNumber=139, createdTime=2018-08-28, rootId=0, userName=zhucaizhong7772, userId=dae718623804, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c3e14e490ab, moduleTitle=CLIN CANCER RES：Andecaliximab单药或联合mFOLFOX6治疗晚期胃及胃食管交界处腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c3e14e490ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598534, encodeId=a6a0159853467, content=<a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a>, objectTitle=mFOLFOX6联合同期新辅助放疗治疗局部进展期直肠癌（FOWARC研究）, objectType=article, longId=56656, objectId=92745665668, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92745665668, replyNumber=0, likeNumber=76, createdTime=2015-09-29, rootId=0, userName=zhucaizhong7772, userId=dae718623804, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92745665668, moduleTitle=mFOLFOX6联合同期新辅助放疗治疗局部进展期直肠癌（FOWARC研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92745665668)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598533, encodeId=7bcf1598533ae, content=<a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a>, objectTitle=Lancet Oncol:增加mFOLFOX6改善直肠癌患者预后, objectType=article, longId=53488, objectId=827353488e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=827353488e2, replyNumber=0, likeNumber=60, createdTime=2015-07-19, rootId=0, userName=zhucaizhong7772, userId=dae718623804, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=827353488e2, moduleTitle=Lancet Oncol:增加mFOLFOX6改善直肠癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=827353488e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598532, encodeId=bd4f1598532de, content=<a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a>, objectTitle=ASCO 2015：中国直肠癌研究FOWARC发现围手术期应用mFOLFOX6化疗方案可能改善DFS, objectType=article, longId=51775, objectId=bc6051e753f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc6051e753f, replyNumber=0, likeNumber=84, createdTime=2015-06-09, rootId=0, userName=zhucaizhong7772, userId=dae718623804, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc6051e753f, moduleTitle=ASCO 2015：中国直肠癌研究FOWARC发现围手术期应用mFOLFOX6化疗方案可能改善DFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc6051e753f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598531, encodeId=823f159853113, content=<a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a>, objectTitle=CCC：Tivozanib联合mFOLFOX6方案治疗进展期胃肠道恶性肿瘤疗效满意, objectType=article, longId=44484, objectId=63814448489, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63814448489, replyNumber=0, likeNumber=102, createdTime=2014-12-24, rootId=0, userName=zhucaizhong7772, userId=dae718623804, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63814448489, moduleTitle=CCC：Tivozanib联合mFOLFOX6方案治疗进展期胃肠道恶性肿瘤疗效满意, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63814448489)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598530, encodeId=080e15985300a, content=<a href='/topic/show?id=ae4d11646ed' target=_blank style='color:#2F92EE;'>#mFOLFOX6#</a>, objectTitle=S-1/奥沙利铂 (SOX)联合贝伐珠单抗与5-FU/l-LV/奥沙利铂(mFOLFOX6)联合贝伐珠单抗治疗转移性结直肠癌(mCRC)(SOFT研究), objectType=article, longId=37048, objectId=c4a63e048dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4a63e048dd, replyNumber=0, likeNumber=60, createdTime=2014-06-27, rootId=0, userName=zhucaizhong7772, userId=dae718623804, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4a63e048dd, moduleTitle=S-1/奥沙利铂 (SOX)联合贝伐珠单抗与5-FU/l-LV/奥沙利铂(mFOLFOX6)联合贝伐珠单抗治疗转移性结直肠癌(mCRC)(SOFT研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4a63e048dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

mFOLFOX6

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#贝伐珠单抗# #CRC# #mFOLFOX6# #利鲁唑#

Clin Cancer Res：利鲁唑联合mFOLFOX6和贝伐珠单抗治疗转移性结直肠癌：一项I期临床试验

2025-03-22发表于陕西省

zhucaizhong7772 (审核中...)

前往app查看评论内容

#mFOLFOX6#

J Clin Oncol：肝切除术后进行mFOLFOX6方案辅助化疗可显著延长仅肝转移的结直肠癌患者的无病生存期！

2021-09-18

zhucaizhong7772 (审核中...)

前往app查看评论内容

#mFOLFOX6#

J Clin Oncol：Andecaliximab联合mFOLFOX6方案作为晚期胃/胃食管交界腺癌的一线疗法的3期试验结果

2021-02-24

zhucaizhong7772 (审核中...)

前往app查看评论内容

#mFOLFOX6#

Lancet oncol：3期试验：FOLFOXIRI+贝伐珠单抗预治疗/再治疗转移性结直肠癌的效果优于mFOLFOX6+贝伐单抗/FOLFIRI+贝伐单抗

2020-03-19

zhucaizhong7772 (审核中...)

前往app查看评论内容

#mFOLFOX6#

DCR：化放疗后巩固mFOLFOX6化疗可改善晚期直肠癌患者的生存率

2018-10-08

zhucaizhong7772 (审核中...)

前往app查看评论内容

#mFOLFOX6#

CLIN CANCER RES：Andecaliximab单药或联合mFOLFOX6治疗晚期胃及胃食管交界处腺癌

2018-08-28

zhucaizhong7772 (审核中...)

前往app查看评论内容

#mFOLFOX6#

mFOLFOX6联合同期新辅助放疗治疗局部进展期直肠癌（FOWARC研究）

2015-09-29

zhucaizhong7772 (审核中...)

前往app查看评论内容

#mFOLFOX6#

Lancet Oncol:增加mFOLFOX6改善直肠癌患者预后

2015-07-19

zhucaizhong7772 (审核中...)

前往app查看评论内容

#mFOLFOX6#

ASCO 2015：中国直肠癌研究FOWARC发现围手术期应用mFOLFOX6化疗方案可能改善DFS

2015-06-09

zhucaizhong7772 (审核中...)

前往app查看评论内容

#mFOLFOX6#

CCC：Tivozanib联合mFOLFOX6方案治疗进展期胃肠道恶性肿瘤疗效满意

2014-12-24

zhucaizhong7772 (审核中...)

前往app查看评论内容

#mFOLFOX6#

S-1/奥沙利铂 (SOX)联合贝伐珠单抗与5-FU/l-LV/奥沙利铂(mFOLFOX6)联合贝伐珠单抗治疗转移性结直肠癌(mCRC)(SOFT研究)

2014-06-27

科室
- - 订阅+
  - 更多科室
工具
服务